tiprankstipranks
Mediwound (MDWD)
NASDAQ:MDWD
US Market
MDWD
Mediwound
RESEARCH TOOLSreports
Want to see MDWD full AI Analyst Report?

Mediwound (MDWD) Stock Forecast & Price Target

440 Followers
See the Price Targets and Ratings of:

MDWD Analyst Ratings

Strong Buy
6Ratings
Strong Buy
6 Buy
0 Hold
0 Sell
Based on 6 analysts giving stock ratings to
Mediwound
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

MDWD Stock 12 Month Forecast

Average Price Target

$29.00
▲(76.83% Upside)
Based on 6 Wall Street analysts offering 12 month price targets for Mediwound in the last 3 months. The average price target is $29.00 with a high forecast of $36.00 and a low forecast of $22.00. The average price target represents a 76.83% change from the last price of $16.40.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"12":"$12","37":"$37","18.25":"$18.25","24.5":"$24.5","30.75":"$30.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":36,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$36.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":29,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$29.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":22,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$22.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[12,18.25,24.5,30.75,37],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.82,15.526153846153846,17.232307692307693,18.93846153846154,20.644615384615385,22.35076923076923,24.056923076923077,25.763076923076923,27.46923076923077,29.175384615384615,30.88153846153846,32.58769230769231,34.293846153846154,{"y":36,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.82,14.987692307692308,16.155384615384616,17.323076923076922,18.49076923076923,19.658461538461538,20.826153846153844,21.993846153846153,23.161538461538463,24.32923076923077,25.496923076923075,26.664615384615384,27.83230769230769,{"y":29,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.82,14.44923076923077,15.07846153846154,15.707692307692309,16.336923076923078,16.966153846153848,17.595384615384617,18.224615384615383,18.853846153846156,19.483076923076922,20.112307692307695,20.74153846153846,21.37076923076923,{"y":22,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":22.24,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.2,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.53,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.6,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.49,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.33,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.21,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.46,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.1,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.41,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.2,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.63,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.82,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$36.00Average Price Target$29.00Lowest Price Target$22.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Maxim Group Analyst forecast on MDWD
Michael Okunewitch
Maxim Group
Maxim Group
$30
Buy
82.93%
Upside
Reiterated
06/01/26
Analysts Offer Insights on Healthcare Companies: Moderna (NASDAQ: MRNA) and Mediwound (NASDAQ: MDWD)
H.C. Wainwright Analyst forecast on MDWD
Swayampakula Ramakanth
H.C. Wainwright
H.C. Wainwright
$14.33→$36
Buy
119.51%
Upside
Reiterated
05/28/26
Ramakanth Reiterates Buy on MDWD, Citing Operational Trial Delay and Solid BARDA-Backed Outlook; $36 Price Target Unchanged
Oppenheimer Analyst forecast on MDWD
Jeff Jones
Oppenheimer
Oppenheimer
$34→$32
Buy
95.12%
Upside
Reiterated
05/28/26
Oppenheimer Sticks to Its Buy Rating for Mediwound (MDWD)
Alliance Global Partners Analyst forecast on MDWD
Scott Henry
Alliance Global Partners
Alliance Global Partners
$25→$22
Buy
34.15%
Upside
Reiterated
05/28/26
MediWound price target lowered to $22 from $25 at Alliance GlobalMediWound price target lowered to $22 from $25 at Alliance Global
TD Cowen Analyst forecast on MDWD
Josh Jennings
TD Cowen
TD Cowen
$25
Buy
52.44%
Upside
Reiterated
05/27/26
TD Cowen Keeps Their Buy Rating on Mediwound (MDWD)
Craig-Hallum Analyst forecast on MDWD
Chase Knickerbocker
Craig-Hallum
Craig-Hallum
―
Buy
―
Reiterated
04/06/26
Analysts Offer Insights on Healthcare Companies: Simulations Plus (NASDAQ: SLP) and Mediwound (NASDAQ: MDWD)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Maxim Group Analyst forecast on MDWD
Michael Okunewitch
Maxim Group
Maxim Group
$30
Buy
82.93%
Upside
Reiterated
06/01/26
Analysts Offer Insights on Healthcare Companies: Moderna (NASDAQ: MRNA) and Mediwound (NASDAQ: MDWD)
H.C. Wainwright Analyst forecast on MDWD
Swayampakula Ramakanth
H.C. Wainwright
H.C. Wainwright
$14.33→$36
Buy
119.51%
Upside
Reiterated
05/28/26
Ramakanth Reiterates Buy on MDWD, Citing Operational Trial Delay and Solid BARDA-Backed Outlook; $36 Price Target Unchanged
Oppenheimer Analyst forecast on MDWD
Jeff Jones
Oppenheimer
Oppenheimer
$34→$32
Buy
95.12%
Upside
Reiterated
05/28/26
Oppenheimer Sticks to Its Buy Rating for Mediwound (MDWD)
Alliance Global Partners Analyst forecast on MDWD
Scott Henry
Alliance Global Partners
Alliance Global Partners
$25→$22
Buy
34.15%
Upside
Reiterated
05/28/26
MediWound price target lowered to $22 from $25 at Alliance GlobalMediWound price target lowered to $22 from $25 at Alliance Global
TD Cowen Analyst forecast on MDWD
Josh Jennings
TD Cowen
TD Cowen
$25
Buy
52.44%
Upside
Reiterated
05/27/26
TD Cowen Keeps Their Buy Rating on Mediwound (MDWD)
Craig-Hallum Analyst forecast on MDWD
Chase Knickerbocker
Craig-Hallum
Craig-Hallum
―
Buy
―
Reiterated
04/06/26
Analysts Offer Insights on Healthcare Companies: Simulations Plus (NASDAQ: SLP) and Mediwound (NASDAQ: MDWD)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Mediwound

3 Months
Michael OkunewitchMaxim Group
Success Rate
11/24 ratings generated profit
46%
Average Return
+4.70%
Copying Michael Okunewitch's trades and holding each position for 3 Months would result in 45.83% of your transactions generating a profit, with an average return of +4.70% per trade.
1 Year
Michael OkunewitchMaxim Group
Success Rate
12/24 ratings generated profit
50%
Average Return
+25.56%
Copying Michael Okunewitch's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +25.56% per trade.
2 Years
Michael OkunewitchMaxim Group
Success Rate
11/24 ratings generated profit
46%
Average Return
+26.33%
Copying Michael Okunewitch's trades and holding each position for 2 Years would result in 45.83% of your transactions generating a profit, with an average return of +26.33% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MDWD Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
4
7
3
7
5
Buy
4
6
6
6
3
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
8
13
9
13
8
In the current month, MDWD has received 8 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. MDWD average Analyst price target in the past 3 months is 29.00.
Each month's total comprises the sum of three months' worth of ratings.

MDWD Financial Forecast

MDWD Earnings Forecast

Next quarter’s earnings estimate for MDWD is -$0.76 with a range of -$0.91 to -$0.68. The previous quarter’s EPS was -$0.23. MDWD beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year MDWD has Performed in-line its overall industry.
Next quarter’s earnings estimate for MDWD is -$0.76 with a range of -$0.91 to -$0.68. The previous quarter’s EPS was -$0.23. MDWD beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year MDWD has Performed in-line its overall industry.

MDWD Sales Forecast

Next quarter’s sales forecast for MDWD is $2.59M with a range of $2.23M to $3.10M. The previous quarter’s sales results were $1.48M. MDWD beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year MDWD has Performed in-line its overall industry.
Next quarter’s sales forecast for MDWD is $2.59M with a range of $2.23M to $3.10M. The previous quarter’s sales results were $1.48M. MDWD beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year MDWD has Performed in-line its overall industry.

MDWD Stock Forecast FAQ

What is MDWD’s average 12-month price target, according to analysts?
Based on analyst ratings, Mediwound’s 12-month average price target is 29.00.
    What is MDWD’s upside potential, based on the analysts’ average price target?
    Mediwound has 76.83% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is MDWD a Buy, Sell or Hold?
          Mediwound has a consensus rating of Strong Buy which is based on 6 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Mediwound’s price target?
            The average price target for Mediwound is 29.00. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $36.00 ,the lowest forecast is $22.00. The average price target represents 76.83% Increase from the current price of $16.4.
              What do analysts say about Mediwound?
              Mediwound’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.
                How can I buy shares of MDWD?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.